APC-2059

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAPC-2059
Drug Alias NameAPC-2059CRA-2059
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTryptase inhibitorsPeptide hydrolase inhibitors
TargetsTryptasePeptide hydrolase
Therapy Area/IndicationsInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCeleraBayer AG
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A